Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EUDA Health Holdings ( (EUDA) ) has shared an update.
On October 23, 2025, EUDA Health Holdings Limited announced that its subsidiary, CK Health Plus, will expand into the Indian market through a strategic partnership with SafeRock India. This collaboration aims to leverage SafeRock India’s extensive network to introduce CK Health Plus’ Bioenergy Capsule Therapies and supplements across major Indian cities, building a sustainable wellness ecosystem. This move positions EUDA to capitalize on India’s growing wellness and preventive healthcare market, driven by a burgeoning middle class and increased focus on long-term health.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. The company aims to become a market leader in non-invasive and preventive healthcare, particularly in the fast-growing longevity sector, addressing the evolving healthcare needs of over 1.8 billion people in the region. EUDA also operates a property management business in Singapore.
Average Trading Volume: 116,435
Technical Sentiment Signal: Hold
Current Market Cap: $117.4M
See more data about EUDA stock on TipRanks’ Stock Analysis page.